谷歌浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.

In situ immune impact of nivolumab plus ipilimumab combination before standard chemoradiation therapy (RTCT) for FIGO IB3-IVA in patients (pts) with cervical squamous carcinoma: COLIBRI trial, a GINECO study

Isabelle Laure Ray-Coquard,Marie-Christine Kaminsky-Forrett,Ryotaro Ohkuma,Aymeric De Montfort,Florence Joly,Isabelle Treilleux, Sarah Ghamry-Barrin,Diana Bello-Roufai,Pierre Saintigny,Antoine Angelergues,Lucas Michon,Anne-Claire Hardy-Bessard,Alexandra Laine,Aude-Marie Savoye,Justine Berthet,Christophe Caux,Fabrice Lecuru,Bertrand Dubois,Sarah Lagarde Betrian

Journal of Clinical Oncology（2023）

引用 0|浏览39
暂无评分
关键词
cervical squamous carcinoma,standard chemoradiation therapy,colibri trial,situ immune impact
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要